1. Home
  2. RBOT vs HLVX Comparison

RBOT vs HLVX Comparison

Compare RBOT & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBOT
  • HLVX
  • Stock Information
  • Founded
  • RBOT 2014
  • HLVX 2020
  • Country
  • RBOT United States
  • HLVX United States
  • Employees
  • RBOT N/A
  • HLVX N/A
  • Industry
  • RBOT Medical Specialities
  • HLVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RBOT Health Care
  • HLVX Health Care
  • Exchange
  • RBOT Nasdaq
  • HLVX Nasdaq
  • Market Cap
  • RBOT 86.1M
  • HLVX 92.9M
  • IPO Year
  • RBOT N/A
  • HLVX 2022
  • Fundamental
  • Price
  • RBOT $12.25
  • HLVX $1.74
  • Analyst Decision
  • RBOT Hold
  • HLVX Hold
  • Analyst Count
  • RBOT 2
  • HLVX 5
  • Target Price
  • RBOT $10.25
  • HLVX $2.33
  • AVG Volume (30 Days)
  • RBOT 35.8K
  • HLVX 176.6K
  • Earning Date
  • RBOT 03-03-2025
  • HLVX 03-19-2025
  • Dividend Yield
  • RBOT N/A
  • HLVX N/A
  • EPS Growth
  • RBOT N/A
  • HLVX N/A
  • EPS
  • RBOT N/A
  • HLVX N/A
  • Revenue
  • RBOT N/A
  • HLVX N/A
  • Revenue This Year
  • RBOT N/A
  • HLVX N/A
  • Revenue Next Year
  • RBOT N/A
  • HLVX N/A
  • P/E Ratio
  • RBOT N/A
  • HLVX N/A
  • Revenue Growth
  • RBOT N/A
  • HLVX N/A
  • 52 Week Low
  • RBOT $4.27
  • HLVX $1.55
  • 52 Week High
  • RBOT $19.00
  • HLVX $20.22
  • Technical
  • Relative Strength Index (RSI)
  • RBOT 51.16
  • HLVX 30.72
  • Support Level
  • RBOT $12.34
  • HLVX $1.86
  • Resistance Level
  • RBOT $14.05
  • HLVX $1.97
  • Average True Range (ATR)
  • RBOT 1.30
  • HLVX 0.07
  • MACD
  • RBOT -0.09
  • HLVX -0.02
  • Stochastic Oscillator
  • RBOT 30.30
  • HLVX 3.27

About RBOT Vicarious Surgical Inc.

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

About HLVX HilleVax Inc.

HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

Share on Social Networks: